Hydrogen peroxide triggers the proteolytic cleavage and the inactivation of calcineurin

Journal of Neurochemistry

Volumn 100, Issue 6, 2007, Pages 1703-1712

  Lee, Ji Eun ^a   Kim, Hyungsoo ^a   Jang, Hyonchol ^a   Cho, Eun Jung ^b   Youn, Hong Duk ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Calcineurin; Hydrogen peroxide; Lysosomal protease; Nuclear factor of activated T cells; Reactive oxygen species

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CALCINEURIN; CALCIUM ION; CHLOROQUINE; HYDROGEN PEROXIDE; NUCLEAR FACTOR; PROTEINASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CALCIUM TRANSPORT; CATALYSIS; CELL TYPE; CONTROLLED STUDY; EMBRYO; ENZYME INACTIVATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; LYSOSOME; MOLECULAR BIOLOGY; MOUSE; NEUROCHEMISTRY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; T LYMPHOCYTE ACTIVATION;

AMYLOID BETA-PROTEIN; ANIMALS; CALCINEURIN; CELLS, CULTURED; CEREBRAL CORTEX; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITORS; HYDROGEN PEROXIDE; MICE; MICE, INBRED ICR; MUTAGENESIS; NEURONS; OXIDANTS; PEPTIDE FRAGMENTS; TIME FACTORS; TRANSFECTION;

EID: 33847761926     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04340.x     Document Type: Article

References (44)

1. Aramburu J., Rao A. and Klee C. B. (2000) Calcineurin: from structure to function. Curr. Top. Cell. Regul. 36, 237-295.
2. Bogumil R., Namgaladze D., Schaarschmidt D., Schmachtel T., Hellstern S., Mutzel R. and Ullrich V. (2000) Inactivation of calcineurin by hydrogen peroxide and phenylarsine oxide. Evidence for a dithiol-disulfide equilibrium and implications for redox regulation. Eur. J. Biochem. 267, 1407-1415.
3. Brunk U. T., Zhang H., Dalen H. and Ollinger K. (1995) Exposure of cells to nonlethal concentrations of hydrogen peroxide induces degeneration-repair mechanisms involving lysosomal destabilization. Free Radic. Biol. Med. 19, 813-822.
4. Burkard N., Becher J., Heindl C., Neyses L., Schuh K. and Ritter O. (2005) Targeted proteolysis sustains calcineurin activation. Circulation 111, 1045-1053.
5. Carballo M., Marquez G., Conde M., Martin-Nieto J., Monteseirin J., Conde J., Pintado E. and Sobrino F. (1999) Characterization of calcineurin in human neutrophils. Inhibitory effect of hydrogen peroxide on its enzyme activity and on NF-kappaB DNA binding. J. Biol. Chem. 274, 93-100.
6. Chang H. Y., Takei K., Sydor A. M., Born T., Rusnak F. and Jay D. G. (1995) Asymmetric retraction of growth cone filopodia following focal inactivation of calcineurin. Nature 376, 686-690.
7. Coghlan V. M., Perrino B. A., Howard M., Langeberg L. K., Hicks J. B., Gallatin W. M. and Scott J. D. (1995) Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 267, 108-111.
8. Crabtree G. R. (2001) Calcium, calcineurin, and the control of transcription. J. Biol. Chem. 276, 2313-2316.
9. Feske S., Okamura H., Hogan P. G. and Rao A. (2003) Ca2+/calcineurin signaling in cells of the immune system. Biochem. Biophys. Res. Commun. 311, 1117-1132.
10. Fuentes J. J., Genesca L., Kingsbury T. J., Cunningham K. W., Perez-Riba M., Estivill X. and de la Luna S. (2000) DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum. Mol. Genet. 9, 1681-1690.
11. Furuke K., Shiraishi M., Mostowski H. S. and Bloom E. T. (1999) Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway. J. Immunol. 162, 1988-1993.
12. Griffith J. P., Kim J. L., Kim E. E., Sintchak M. D., Thomson J. A., Fitzgibbon M. J., Fleming M. A., Caron P. R., Hsiao K. and Navia M. A. (1995) X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell 82, 507-522.
13. Kissinger C. R., Parge H. E., Knighton D. R. et al. (1995) Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature 378, 641-644.
14. Koh J. Y., Gwag B. J., Lobner D. and Choi D. W. (1995) Potentiated necrosis of cultured cortical neurons by neurotrophins. Science 268, 573-575.
15. Kusakawa G., Saito T., Onuki R., Ishiguro K., Kishimoto T. and Hisanaga S. (2000) Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J. Biol. Chem. 275, 17 166-17 172.
16. Lai M. M., Burnett P. E., Wolosker H., Blackshaw S. and Snyder S. H. (1998) Cain, a novel physiologic protein inhibitor of calcineurin. J. Biol. Chem. 273, 18 325-18 331.
17. Lee M. S., Kwon Y. T., Li M., Peng J., Friedlander R. M. and Tsai L. H. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364.
18. Lin X. and Barber D. L. (1996) A calcineurin homologous protein inhibits GTPase-stimulated Na-H exchange. Proc. Natl Acad. Sci. USA 93, 12 631-12 636.
19. Liu J., Farmer J. D. Jr, Lane W. S., Friedman J., Weissman I. and Schreiber S. L. (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815.
20. Liu F., Grundke-Iqbal I., Iqbal K., Oda Y., Tomizawa K. and Gong C. X. (2005) Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J. Biol. Chem. 280, 37 755-37 762.
21. Mansuy I. M., Mayford M., Jacob B., Kandel E. R. and Bach M. E. (1998) Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell 92, 39-49.
22. Meguro T., Hong C., Asai K., Takagi G., McKinsey T. A., Olson E. N. and Vatner S. F. (1999) Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. Circ. Res. 84, 735-740.
23. Molkentin J. D., Lu J.R., Antos C. L., Markham B., Richardson J., Robbins J., Grant S. R. and Olson E. N. (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215-228.
24. Mondragon A., Griffith E. C., Sun L., Xiong F., Armstrong C. and Liu J. O. (1997) Overexpression and purification of human calcineurin alpha from Escherichia coli and assessment of catalytic functions of residues surrounding the binuclear metal center. Biochemistry 36, 4934-4942.
25. Mukerjee N., McGinnis K. M., Park Y. H., Gnegy M. E. and Wang K. K. (2000) Caspase-mediated proteolytic activation of calcineurin in thapsigargin-mediated apoptosis in SH-SY5Y neuroblastoma cells. Arch. Biochem. Biophys. 379, 337-343.
26. Namgaladze D., Hofer H. W. and Ullrich V. (2002) Redox control of calcineurin by targeting the binuclear Fe(2+)-Zn(2+) center at the enzyme active site. J. Biol. Chem. 277, 5962-5969.
27. Nixon R. A., Mathews P. M. and Cataldo A. M. (2001) The neuronal endosomal-lysosomal system in Alzheimer's disease. J. Alzheimers Dis. 3, 97-107.
28. de la Pompa J. L., Timmerman L. A., Takimoto H. et al. (1998) Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392, 182-186.
29. Ranger A. M., Grusby M. J., Hodge M. R., Gravallese E. M., de la Brousse F. C., Hoey T., Mickanin C., Baldwin H. S. and Glimcher L. H. (1998) The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392, 186-190.
30. Reiter T. A. and Rusnak F. (2002) Is calcineurin a peroxide-specific sensor in T-lymphocytes? J. Biol. Inorg. Chem. 7, 823-834.
31. Reiter T. A., Abraham R. T., Choi M. and Rusnak F. (1999) Redox regulation of calcineurin in T-lymphocytes. J. Biol. Inorg. Chem. 4, 632-644.
32. Rothermel B., Vega R. B., Yang J., Wu H., Bassel-Duby R. and Williams R. S. (2000) A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J. Biol. Chem. 275, 8719-8725.
33. Shibasaki F., Price E. R., Milan D. and McKeon F. (1996) Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 382, 370-373.
34. Sisodia S. S. and St George-Hyslop P. H. (2002) gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat. Rev. Neurosci. 3, 281-290.
35. Sommer D., Fakata K. L., Swanson S. A. and Stemmer P. M. (2000) Modulation of the phosphatase activity of calcineurin by oxidants and antioxidants in vitro. Eur. J. Biochem. 267, 2312-2322.
36. Sun L., Youn H. D., Loh C., Stolow M., He W. and Liu J. O. (1998) Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes. Immunity 8, 703-708.
37. Sussman M. A., Lim H.W., Gude N., Taigen T., Olson E. N., Robbins J., Colbert M. C., Gualberto A., Wieczorek D. F. and Molkentin J. D. (1998) Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 281, 1690-1693.
38. Wang X., Culotta V. C. and Klee C. B. (1996) Superoxide dismutase protects calcineurin from inactivation. Nature 383, 434-437.
39. Winder D. G., Mansuy I. M., Osman M., Moallem T. M. and Kandel E. R. (1998) Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin. Cell 92, 25-37.
40. Wu H. Y., Tomizawa K., Oda Y., Wei F. Y., Lu Y. F., Matsushita M., Li S. T., Moriwaki A. and Matsui H. (2004) Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J. Biol. Chem. 279, 4929-4940.
41. Yankner B. A. (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
42. Youn H. D., Chatila T. A. and Liu J. O. (2000) Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J. 19, 4323-4331.
43. Yu L., Haddy A. and Rusnak F. (1995) Evidence that calcineurin accommodates an active site binuclear metal center. J. Am. Chem. Soc. 117, 10 147-10 148.
44. Yu L., Golbeck J., Yao J. and Rusnak F. (1997) Spectroscopic and enzymatic characterization of the active site dinuclear metal center of calcineurin: implications for a mechanistic role. Biochemistry 36, 10 727-10 734.